SXTP - שווי שוק לנפח מכירות 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals (SXTP) commercializes treatments for tropical infections to protect military personnel and tourists. The price-to-sales ratio trend on the GURU.Markets chart shows that the value is holding at 1.10. Government contracts and clinics ensure stable demand. The business relies on a high-leverage patent model, utilizing distributors to scale without increasing headcount.

Due to its monopoly position in the antimalarial segment and the inelastic demand for Arakoda, 60 Degrees Pharmaceuticals (SXTP) possesses significant pricing power. This enterprise value-to-revenue multiple correlates market capitalization with annual turnover, allowing investors to track business valuation phases in real-time and promptly identify correction risks during extreme metric deviations.